Physician profile
Jared E Spector
NPI 1629048004
$5,126.92
in general payments reported to CMS, 2019-2025
25 companies · $732 in 2025
The $732 reported for 2025 was more than what 82% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $449 · 2021: $884 · 2022: $835 · 2023: $832 · 2024: $797 · 2025: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,305 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,304.71 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,021.89 | 2019-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $833.90 | 2019-2025 | |
| Glaxosmithkline, LLC. | $783.59 | 2019-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $509.30 | 2019-2025 | Tezspire |
| Stryker Corporation | $462.86 | 2021-2025 | Audion Et Dilation System, Focess Hd Wireless Camera |
| Optinose US, INC. | $202.24 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $195.09 | 2019-2025 | |
| Medtronic, INC. | $192.75 | 2021-2025 | Nuvent, Propel |
| Alk-Abello, INC | $128.17 | 2019-2023 | Grastek, Ragwitek, Odactra |
| Aerin Medical INC. | $127.64 | 2019-2025 | |
| Genentech USA, INC. | $97.27 | 2019-2022 | |
| Phadia US INC. | $97.07 | 2019-2025 | Immunocap |
| Medtronic USA, INC. | $94.33 | 2019-2020 | |
| Ars Pharmaceuticals Operations, INC. | $59.18 | 2025 | Neffy |
| Intersect Ent, INC. | $57.58 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $51.48 | 2022-2024 | Tavneos |
| Phathom Pharmaceuticals, INC. | $34.03 | 2024 | Voquezna |
| Hikma Pharmaceuticals USA | $33.34 | 2024 | Ryaltris |
| Acclarent, INC | $29.16 | 2021-2022 | |
| Inspire Medical Systems, INC. | $28.27 | 2025 | Inspire |
| Masimo Corporation | $23.93 | 2024 | Patient Safetynet System |
| Lucid Diagnostics INC. | $19.45 | 2025 | |
| Photonicare INC | $15.28 | 2025 | Otosight Middle Ear Scope |
| Smith+Nephew, INC. | $15.24 | 2025 | Tula |
| Sanofi-Aventis U.S. LLC | $13.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Spector listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.